News & Media

Keeping our Media Partners in the Loop

5 March 2025

Pharmascience Canada expands its portfolio with a treatment for Parkinson’s disease patients

Read the article

6 February 2025

Pharmascience Canada strengthens its commitment to patients with an antihistamine treatment

Read the article

26 November 2024

Pharmascience Canada launches Pr pms-PALBOCICLIB, a treatment for breast cancer

Read the article

23 September 2024

Pharmascience Canada launches a new medication for its patient

Read the article

9 September 2024

Pendopharm announces public drug coverage plan listings for Octasa® (oral mesalamine)

Read the article

9 July 2024

Pendopharm signs exclusive distribution agreement with Ascendis Pharma A/S for TransCon™ PTH in Canada

Read the article

1 2 3 4 5 6 7 8 9 … 13

Media Relations

Please send us an email and provide us with your contact information as well as the name of your media/publication/source. A member of our team will contact you back quickly.

Topics

All Award/Recognition Business News Buying Locally COVID Employer Awards Our Divisions Product Launches Public Stance

About Pharmascience

Since 1983, Pharmascience has been a leading Canadian manufacturer of generic, branded, and over-the-counter pharmaceuticals, serving both domestic and international markets.

About Us

Professional Services Portal (Canada)

Healthcare Professional Authentication or Access? (Canada)

Keeping our Media Partners in the Loop

Pharmascience Canada expands its portfolio with a treatment for Parkinson’s disease patients

Pharmascience Canada strengthens its commitment to patients with an antihistamine treatment

Pharmascience Canada launches Pr pms-PALBOCICLIB, a treatment for breast cancer

Pharmascience Canada launches a new medication for its patient

Pendopharm announces public drug coverage plan listings for Octasa® (oral mesalamine)

Pendopharm signs exclusive distribution agreement with Ascendis Pharma A/S for TransCon™ PTH in Canada